An example of the annotation provided by a new software tool for RNA secondary structure researchers. [Source: David Hendrix/OSU College of Science]

RNA Gets Big-Data-Enabled Structural Analysis and Annotation Tool

The tool's in-depth analysis of RNA molecules will provide better information of the connections between mutant genetic material and disease
Source: © ktsdesign/Fotolia

Natera Revenues Fall in Q4 Despite Growth in Number of Tests

The developer of molecular diagnostic tests reported Q4 revenues of $49.3 million, down from $52.9 million in the year-ago quarter

Guardant to Acquire Bellwether Bio, Adding to Early-Stage Cancer Dx Pipeline

Guardant Health will acquire Bellwether Bio, in a deal designed to advance the buyer’s pipeline of early-detection cancer diagnostics.
Thermo Fisher Scientific and The Wellcome Trust Sanger Institute have co-developed the Applied Biosystems Axiom African Array to capture genome-wide variation in African populations. [Source: rphotos/Fotolia]

Thermo Fisher Scientific, Wellcome Trust Sanger Launch Axiom Africa Array

Thermo Fisher Scientific and The Wellcome Trust Sanger Institute develop an array to capture genome-wide variation in African populations
GenomeDx Biosciences has agreed to pay the U.S. federal government $1.99 million to settle allegations that it submitted false claims to Medicare for the Decipher post-operative genetic test for prostate cancer patients. [National Cancer Institute

GenomeDx to Pay $1.99M to Settle Medicare Billing Allegations

Company accused of submitting false claims to Medicare for the Decipher prostate cancer test between September 2015 and June 2017
Source: Getty Images

Perturb-Seq Combines CRISPR and Single-Cell RNA-Seq

High-Throughput Method Developed by UC San Francisco and Broad Researchers Allows for the Screening of Complex Genetic Interactions.
Source: KTSDESIGN/SCIENCE PHOTO LIBRARY/Getty Images

New DNA Damage Repair Insights Point to Cancer Treatment Options

German researchers break new ground in the understanding of chromothirpsis, implicating the failure of a cell's genetic repair system
Source: royaltystockphoto/Getty Images

Research Consortium IDs 72 New Genetic Risk Variants for Breast Cancer

Researchers use data from 275,000 women for a genome-wide association study that found seven variants specific to ER-negative breast cancer
Sysmex and MolecularMD will partner to develop and commercialize companion diagnostics for precision medicines through a master collaboration agreement whose value was not disclosed.[© Alex Tihonov/Fotolia]

Sysmex, MolecularMD Partner on Precision Medicine Companion Diagnostics

Companies aim to accelerate commercialization of CDx and therapeutics, as well as leverage their experience with regulators
A new study uses data from humans and worms to generated new insights into the mutational causes of cancer. [A new study uses data from humans and worms to generated new insights into the mutational causes of cancer. [HeitiPaves

C. elegans Study Offers Insights into Cancer Mutation Origins in Humans

Researchers refine what they know about cancer by using C. elegans as a model system for studying DNA mismatch repair in greater detail
Scroll Up